Alpha-1-antitrypsin deficiency (AATD) is a rare genetic disorder associated with the development of liver and lung disease. AAT is a 52-kD glycoprotein, produced mainly by hepatocytes and secreted into the blood
Alpha-1抗胰蛋白酶缺乏症的英文名字是Alpha-1 antitrypsin deficiency。基因解码表明:Alpha-1抗胰蛋白酶缺乏症是一种遗传性疾病,与基因突变密切相关。Alpha-1抗胰蛋白酶是一种由SERPINA1基因编码的蛋白质,它在肝脏中合成并通过血液循环分布到全身。该蛋白质的主要功能是
ALPHA 1 ANTITRYPSIN DEFICIENCY IN THE PATHOGENESIS (OF BRONCHOPULMONARY DYSPLASIABronchopulmonary Dysplasia (BPD) is a major cause of neonatal respiratory morbidity and mortality. The pathophysiology of BPD may be related to an absence of the antiprotease alpha 1 anti-trypsin (αLat) in pulmonary ...
AAT, alpha-1 antitrypsin; AATD, alpha-1 antitrypsin deficiency; LSM, liver stiffness measurement; PAS-D, periodic acid-Schiff-diastase; Pi∗M, normal AAT allele; Pi∗S, mutant SERPINA1 allele variant termed ‘S’; Pi∗Z, mutant SERPINA1 allele variant termed ‘Z’; Pi∗MZ, AAT geno...
About Alpha-1 Antitrypsin Deficiency (AATD) and KRRO-110 AATD is a genetic disorder most commonly caused by a single missense mutation (G-to-A) in the SERPINA1 gene. Affected adults experience pulmonary emphysema and/or hepatic cirrhosis, as well as end organ manifestations. KR...
Alpha1-Proteinase Inhibitor (Human), ZEMAIRA® is indicated to raise the plasma level of alpha1-proteinase inhibitor (A1-PI) in patients with A1-PI deficiency and related emphysema.
Alpha-1 antitrypsin(抗胰蛋白酶)deficiency is a genetic disorder(遗传病)in which a protein called alpha-1antitrypsin is defective or absent, and it causes lung and liver disease. α抗胰蛋白酶缺乏症是一种遗传性疾病,患者体内的一种叫做α抗胰蛋白酶的蛋白质出现了问题或者含量减少了,最终导致肺和肝脏...
Alpha1-Proteinase Inhibitor (Human), ZEMAIRA® is indicated to raise the plasma level of alpha1-proteinase inhibitor (A1-PI) in patients with A1-PI deficiency and related emphysema.
ARALAST® NP [Alpha1-Proteinase Inhibitor (Human)] is a medication for severe Alpha 1-antitrypsin deficiency with emphysema. See Important Safety Information.
Alpha-1 antitrypsin deficiency associated liver disease (AATD-LD) is a leading genetic cause of liver disease, yet it remains largely underdiagnosed and poorly understood. This encore webinar from a live symposium will feature a multispecialty panel of experts who will...